Tessella Support Services plc has announced that Rachel Hirst has joined the life sciences business development team, supporting clients in the UK, USA, and Europe
Tessella provides innovative informatics spanning the drug discovery process.
Rachel Hirst obtained a DPhil in reproductive molecular biology from the University of Leeds and subsequently was a post-doctoral research scientist at the University of Oxford.
Kevin Gell, managing director of Tessella said: "Over ten years' experience working with most of the major pharmaceutical companies, and a large number of businesses involved in emergent technologies such as bioinformatics and pharmacogenomics, means that Tessella understands clients' business and technical requirements and is able to provide them with custom-built, innovative solutions, throughout the whole drug pipeline".
Hirst commented: "The exceptional scientific backgrounds of Tessella's business development and technical staff are key to ensuring that the company really understands the needs of life sciences clients and can add real value to their operations."
